ArticleInvestigative ophthalmology & visual science2026
Tissue-Specific Antioxidant Capacity in Primary Open-Angle Glaucoma Patients.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: To evaluate antioxidant capacity in aqueous humor (AH), trabecular meshwork (TM), and lens epithelium (LE) from patients with primary open-angle glaucoma and cataract and to assess associations with race and disease severity. Methods: In this prospective cross-sectional study, two surgical cohorts undergoing cataract with glaucoma surgery provided either AH or paired TM/LE. AH total reactive antioxidant potential and ascorbic acid were measured. In paired TM and LE from the same eye, qPCR assessed nuclear factor erythroid 2-related factor 2 (NRF2), catalase (CAT), and superoxide dismutase 2. For AH, group comparisons used Welch's t tests or Mann-Whitney tests, and severity-stratified analyses used Race × Severity two-way ANOVA with Šídák correction. For qPCR, within-eye differences were calculated as Δ(TM - LE); race comparisons used Welch's t tests for each marker, with Šídák correction across the three markers. Results: AH was analyzed from 106 eyes (Black n = 37; White n = 69); no race differences remained after Race × Severity modeling with Šídák adjustment. Paired TM/LE qPCR was analyzed from 42 eyes (Black n = 21; White n = 21). In Black eyes, NRF2 and CAT were lower in TM relative to matched LE (both P < 0.0001), whereas no such paired tissue differences were detected in White eyes. The within-eye difference Δ(TM - LE) was more negative in Black than White eyes for NRF2 (P = 0.0001) and CAT (P = 0.0024). Superoxide dismutase 2 showed no race-associated difference. Conclusions: AH antioxidant measures showed limited race-associated differences, whereas paired TM/LE profiling revealed tissue- and marker-specific expression differences most evident in Black patients. These compartment-specific signatures warrant validation in larger prospective cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.